Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data

CNS Neurol Disord Drug Targets. 2023;22(2):161-171. doi: 10.2174/1871527320666210902164235.

Abstract

Present time nosology has its roots in Kraepelin's demarcation of schizophrenia and bipolar disorder. However, accumulating evidence has shed light on several commonalities between the two disorders, and some authors have advocated for the consideration of a disease continuum. Here, we review previous genetic, biological and pharmacological findings that provide the basis for this conceptualization. There is a cross-disease heritability, and they share single-nucleotide polymorphisms in some common genes. EEG and imaging patterns have a number of similarities, namely reduced white matter integrity and abnormal connectivity. Dopamine, serotonin, GABA and glutamate systems have dysfunctional features, some of which are identical among the disorders. Finally, cellular calcium regulation and mitochondrial function are, also, impaired in the two.

Keywords: Bipolar; continuum; genetics; neurobiology; pharmacology; schizophrenia.

Publication types

  • Review

MeSH terms

  • Bipolar Disorder* / drug therapy
  • Bipolar Disorder* / genetics
  • Humans
  • Schizophrenia* / drug therapy
  • Schizophrenia* / genetics